Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2000-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.69.5.590PMID 11032609PMCID PMC1763425
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.

  2000cited by this paper
• Failure of the clonidine growth hormone stimulation test to differentiate multiple system atrophy from early or advanced idiopathic Parkinson's disease.

  1999cited by this paper
• Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy

  1999cited by this paper
• Short‐term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease

  1997cited by this paper
• Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.

  1997cited by this paper
• PET and SPECT studies in Parkinson's disease.

  1997cited by this paper
• [Apomorphine test: evaluation of dopaminergic response in patients with Parkinson disease].

  1995cited by this paper
• The levodopa test in Parkinson's disease.

  1995cited by this paper
• Prueba de apomorfina : evaluacion de la respuesta dopaminergica en parkinsonismos

  1995cited by this paper
• [The apomorphine test in the differential diagnosis of Parkinsonism. Initial experience].

  1994cited by this paper
• 123I‐Iodobenzamide‐SPECT in 83 patients with de novo parkinsonism

  1993cited by this paper
• Apomorphine test for dopaminergic responsiveness: A dose assessment study

  1993cited by this paper
• Correlation of clinical response in apomorphine test with D2‐receptor status as demonstrated by 123I IBZM‐SPECT

  1993cited by this paper
• [The apomorphine test in Parkinson's disease: diagnostic value].

  1993cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease.

  1992cited by this paper
• Challenge tests to predict the dopaminergic response in untreated Parkinson's disease

  1991cited by this paper
• The apomorphine test in parkinsonian syndromes.

  1991cited by this paper
• Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes.

  1990influential reference
• APOMORPHINE TEST FOR DOPAMINERGIC RESPONSIVENESS

  1989cited by this paper
• Statistical methods for rates and proportions

  1973influential reference

• Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis

  2025cites this paper
• Instrumented timed up and go test and machine learning-based levodopa response evaluation: a pilot study

  2024cites this paper
• Dopa Responsiveness in Parkinson's Disease

  2024cites this paper
• Definition and diagnosis of Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology

  2024influential citation
• Parkinson’s disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment

  2023cites this paper
• Apomorphine subcutaneous titration in Parkinson’s disease - the effectiveness and safety of apomorphine challenges: A Literature Review

  2023cites this paper
• Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.

  2023cites this paper
• Review on Potential combination therapy in treatment of Parkinson disease and related Dementia Disorders: Emphasises on Safinamide

  2022cites this paper
• Parkinsonism

  2021cites this paper
• Practical aspects of prescribing antiparkinsonian drugs. The place of amantadines in the management of Parkinson’s disease

  2021cites this paper
• Parkinson’s Disease–An Introduction

  2021cites this paper
• Quantitative Assessment of Motor Response to a Low Subacute Levodopa Dose in the Differential Diagnosis of Parkinsonisms at Disease Onset: Data from the BoProPark Cohort

  2021cites this paper
• Levodopa challenge test: indications, protocol, and guide

  2020cites this paper
• Quantification of tremor severity with a mobile tremor pen

  2020influential citation
• Machine Learning Methods for Managing Parkinson’s Disease

  2019cites this paper
• L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression.

  2019cites this paper
• Old Drugs, New Delivery Systems in Parkinson’s Disease

  2019cites this paper
• Pruebas Terapéuticas Con Fines Diagnósticos En Trastornos Del Movimiento

  2019cites this paper
• UPSALIENSIS UPPSALA 2018 Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1437 New Approaches for Levodopa Treatment in Parkinson ’ s Disease MARINA

  2018cites this paper
• Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort

  2017cites this paper
• [Practical use of continuous apomorphine infusion via pump].

  2017cites this paper
• Current trends in etiology, prognosis and therapeutic aspects of Parkinson’s disease: a review

  2017cites this paper
• Unmasking levodopa resistance in Parkinson's disease

  2016cites this paper
• l‐DOPA‐induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?

  2016cites this paper
• Tracing tremor: Neural correlates of essential tremor and its treatment

  2016cites this paper
• Катунина Е.А., Бездольный Ю.Н., Малыхина Е.А., Титова Н.В. Кафедра неврологии, нейрохирургии и медицинской генетики ГБОУ ВПО «Российский национальный исследователь- ский университет им. Н.И. Пирогова» Минздрава России, Москва 117997, Москва, ул. Островитянова, 1

  2015cites this paper
• Apomorphine hydrochloride for the treatment of Parkinson’s disease

  2015cites this paper
• Diagnostic procedures during the course of Parkinson's Disease

  2014cites this paper
• Multiple System Atrophy

  2014cites this paper
• Clinicoradiological comparison between vascular parkinsonism and Parkinson’s disease

  2014cites this paper
• Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes

  2013cites this paper
• Levodopa challenge test and 123I‐metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease

  2013cites this paper
• Hypothalamic dopaminergic stimulation in cluster headache

  2013cites this paper
• 123I-Iodobenzamide SPECT Is Not an Independent Predictor of Dopaminergic Responsiveness in Patients with Suspected Atypical Parkinsonian Syndromes

  2013cites this paper
• EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease

  2013cites this paper
• Vascular parkinsonism: a case series of 17 patients.

  2013cites this paper
• Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa.

  2013cites this paper
• Parkinson's Disease Nurse Specialists and the King's College Hospital model of care

  2013cites this paper
• Levodopa en el tratamiento de la enfermedad de Parkinson: mitos y realidades

  2012cites this paper
• How to Tackle Tremor – Systematic Review of the Literature and Diagnostic Work-Up

  2012cites this paper
• [Levodopa in the treatment of Parkinson's disease: myths and realties].

  2012cites this paper
• [Proposed alternative to standard apomorphine challenge test].

  2012cites this paper
• Role of DatScan imaging in diagnosis of Parkinson ' s Disease

  2012cites this paper
• Comprehensive Overview of Methods and Reporting of Meta-Analyses of Test Accuracy

  2012cites this paper
• Implications for managed care for improving outcomes in Parkinson's disease: balancing aggressive treatment with appropriate care.

  2011cites this paper
• Validation of 24-hour ambulatory gait assessment in Parkinson's disease with simultaneous video observation

  2011cites this paper
• Apomorphintest The Apomorphine Test

  2011cites this paper
• [Levodopa medications in the treatment of Parkinson's disease].

  2011cites this paper
• Multiple System Atrophy: Clinical Features and Management

  2010cites this paper
• The clinical spectrum of levodopa-induced motor complications

  2010cites this paper
• Levodopa in the treatment of Parkinson’s disease: an old drug still going strong

  2010influential citation
• ["Red flags": when to be alerted and how to explore?].

  2010cites this paper
• Acute stepwise challenge test with levodopa in treated patients with parkinsonism.

  2009cites this paper
• Guidelines Network Part of NHS Quality Improvement Scotland SIGN Diagnosis and pharmacological management of Parkinson ’ s disease

  2009cites this paper
• Parkinson disease: systemic and orofacial manifestations, medical and dental management.

  2009cites this paper
• diagnosis Parkinson's disease: clinical features and

  2008cites this paper
• Singapore general practitioners' awareness of atypical features in early Parkinson's disease.

  2007cites this paper
• Parkinsonism: A Review-of-Systems Approach to Diagnosis

  2007cites this paper
• [Apomorphine in off state--clinical experience].

  2007cites this paper
• American Academy of Neurology evidence-based review): Report of the Quality Standards Subcommittee of the Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an

  2007cites this paper
• Chapter 4 – Parkinsonism: Clinical Features and Differential Diagnosis

  2007cites this paper
• Approach to diagnosis of Parkinson disease.

  2006cites this paper
• Is it Parkinson’s disease, and if not, what is it?

  2006cites this paper
• Disease Progression and Pharmacodynamics in Parkinson Disease – Evidence for Functional Protection with Levodopa and Other Treatments

  2006cites this paper
• Effect of levodopa on cognitive function in Parkinson’s disease with and without dementia and dementia with Lewy bodies

  2006cites this paper
• Extensive brain calcification in idiopathic hypoparathyroidism

  2006cites this paper
• Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson’s disease

  2006cites this paper
• The diagnosis of Parkinson's disease.

  2006cites this paper
• Parkinsonism and Anderson Fabry's disease: A case report

  2006cites this paper
• Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review)

  2006cites this paper
• The role of levodopa in the management of dementia with Lewy bodies

  2005cites this paper
• A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy.

  2005cites this paper
• A15 Initial clinical experience with 123I ioflupane scintigraphy in movement disorders

  2005cites this paper
• Apomorphine: an overview of clinical use

  2005cites this paper
• [Apomorphine in the treatment of Parkinson's Disease].

  2005cites this paper
• Initial clinical experience with [123I]ioflupane scintigraphy in movement disorders.

  2005cites this paper
• Apomorphin bei der Behandlung des Morbus Parkinson

  2005cites this paper
• Analysis of the course of Parkinson's disease under dopaminergic therapy: Performance of “fast tapping” is not a suitable parameter

  2005cites this paper
• Diagnosis and Initial Management of Parkinson's Disease

  2005cites this paper
• Clinical practice. Diagnosis and initial management of Parkinson's disease.

  2005cites this paper
• Differential response in choice reaction time following apomorphine based on prior dopaminergic treatment

  2004cites this paper
• An overview of parkinsonian syndromes: data from the literature and from an Italian data-base.

  2004cites this paper
• Other formulations and future considerations for apomorphine for subcutaneous injection therapy

  2004cites this paper
• Vascular parkinsonism

  2004cites this paper
• [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].

  2004cites this paper
• Levodopa treatment does not affect low‐dose apomorphine test in patients with Parkinson's disease

  2004cites this paper
• Does this patient have Parkinson disease?

  2003cites this paper
• Repeated rating improves value of diagnostic dopaminergic challenge tests in Parkinson's disease

  2003influential citation
• Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders

  2003cites this paper
• SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

  2003cites this paper
• Identification of parkinsonism and Parkinson's disease.

  2002cites this paper
• Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes

  2001cites this paper
• Prospective assessment of falls in Parkinson's disease

  2001cites this paper
• Updated guidelines for the management of Parkinson's disease.

  2001cites this paper
• Clinical Interventions in Aging Dovepress Levodopa in the Treatment of Parkinson's Disease: an Old Drug Still Going Strong

  year unknowncites this paper
• 17 Levodopa

  year unknowncites this paper
• PHARMACEUTICAL CARE ( 14 ) PARKINSON ’ S DISEASE

  year unknowncites this paper